Emmanuel Coronel Cordero, MD
Gastroenterology · Houston, TXNPI 1437445905
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 60.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $3,375 and has fallen 88.5% since, to $388 in 2025.
Across 63 payments — averaging $135.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Pentax Of America, Inc.$2K
- Conmed Corporation$320
- Cook Medical LLC$190
- Olympus America Inc.$152
- Fujifilm Healthcare Americas Corporation$151
- plus $246 from 6 others
What the payments were for
- Consulting fees$3,75044%
- Speaking & faculty fees$2,00023%
- Food & beverage$2,79233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 33 | $5,171 |
| Pentax Of America, Inc. | 6 | $2,312 |
| Conmed Corporation | 8 | $320 |
| Cook Medical LLC | 2 | $190 |
| Olympus America Inc. | 7 | $152 |
| Fujifilm Healthcare Americas Corporation | 1 | $151 |
| Micro-tech Endoscopy USA, Inc. | 1 | $128 |
| Apollo Endosurgery US Inc | 1 | $31 |
| KARL Storz Endoscopy-america | 1 | $27 |
| Creo Medical Inc. | 1 | $21 |
| ERBE USA Inc | 1 | $20 |
| Medtronic | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$3,869
- ORISE$235
- FUJIFILM$151
- eyeMax$128
- Hemospray$127
- CONMED POLYPECTOMY$110
- AXIOS$102
How this compares
$8,542 in reported general payments places this provider in the 75th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 13 | $383 |
| Pantoprazole Sodium | 24 | $223 |
| Levofloxacin | 19 | $20 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Houston
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Brooks CashHouston$867K
- Mohamed OthmanHouston$777K
- Isaac RaijmanHouston$565K
- Kalpesh PatelHouston$382K
- Victor Ankoma-SeyHouston$340K
- John VierlingHouston$270K
- George TriadafilopoulosHouston$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.